Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer.
Clin Lung Cancer
; 18(1): e81-e83, 2017 01.
Article
in En
| MEDLINE
| ID: mdl-27863924
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quinazolines
/
Adenocarcinoma
/
Lung Diseases, Interstitial
/
Drug-Related Side Effects and Adverse Reactions
/
Erlotinib Hydrochloride
/
Lung Neoplasms
/
Antineoplastic Agents
Type of study:
Etiology_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Clin Lung Cancer
Journal subject:
NEOPLASIAS
Year:
2017
Type:
Article